LEADER 02164nam0 2200481 i 450 001 VAN00102937 005 20240806100721.747 017 70$2N$a978-1-4939-1100-4 100 $a20151015d2014 |0itac50 ba 101 $aeng 102 $aUS 105 $a|||| ||||| 200 1 $aPractical considerations for adaptive trial design and implementation$fWeili He, José Pinheiro, Olga M. Kuznetsova editors 210 $aNew York$cSpringer$d2014 215 $aXX, 416 p.$cill.$d24 cm 410 1$1001VAN00102850$12001 $aStatistics for biology and health$1210 $aBerlin [etc.]$cSpringer$d1992- 500 1$3VAN00239890$aPractical considerations for adaptive trial design and implementation$91410705 606 $a62-XX$xStatistics [MSC 2020]$3VANC022998$2MF 606 $a92-XX$xBiology and other natural sciences [MSC 2020]$3VANC020839$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 610 $aAdaptive Clinical Trials$9KW:K 610 $aAdaptive designs$9KW:K 610 $aAdaptive simulation$9KW:K 610 $aClinical supply modeling$9KW:K 610 $aOptimal dose selection$9KW:K 610 $aPharmaceutical clinical trials$9KW:K 610 $aProbability of success$9KW:K 610 $aRandomized Clinical Trials$9KW:K 610 $aRegulatory agency and clinical trials$9KW:K 610 $apharmaceutical trial design$9KW:K 620 $aUS$dNew York$3VANL000011 702 1$aHe$bWeili$3VANV080355 702 1$aKuznetsova$bOlga M.$3VANV080357 702 1$aPinheiro$bJosé$3VANV080356 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240906$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-1-4939-1100-4$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN00102937 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 4711 $e15EB 4711 20191107 996 $aPractical considerations for adaptive trial design and implementation$91410705 997 $aUNICAMPANIA